Skip to main content
SpringerLink
Log in

Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (≤1.5 mm) melanoma

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

Patients who died of a melanoma thinner than 1.5mm within 96 months (group 1, n=60) were compared with those having a tumor of the same thickness who had not died in this time period (Group 2, n=300). Both groups were investigated with respect to differences in patients sex and age and to thickness, diameter, exophytic growth, and site of the melanoma as well as the number of mitoses/mm2 of tumor area. Relatively speaking, more men than women died of a thin melanoma: in Group 1 (deceased) there were 32 men and 28 women, in Group 2 (alive) 58 men and 242 women. The better survival rate of females did not depend on the difference in the predominating melanoma locations (♀face and legs; ♂ trunk): in both sites, on the legs and on the trunk, women had a significantly higher 8-year survival rate than men with equally thick tumors. Furthermore, melanomas on the arms and legs of females had a better prognosis than those on the trunk and face. Both the patient's sex and the tumor site seem to influence the survival of melanoma patients. Only in men was the median of mitoses/mm2 of tumor area found to be higher in the first group (2.2) than in the second group (0.75). In women, no marked difference in the mitotic count was found (Group 1:1.1; Group 2:1.15).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ariel IM (1982) Malignant melanoma of the trunk: A retrospective review of 1128 patients. Cancer 49:1070–1078

    Google Scholar 

  2. Balch CM, Murad TM, Soong S-J, Ingalls AL, Halpern NB, Maddox WA (1978) A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 188:732–742

    Google Scholar 

  3. Breslow A (1975) Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 182:572–575

    Google Scholar 

  4. Breslow A (1980) Prognosis in cutaneous melanoma. Tumor thickness as a guide to treatment. Patholol Annu 15/I:1–22

    Google Scholar 

  5. Cascinelli N, Morabito A, Bufalino R, Van der Esch EP, Preda F, Vaglini M, Rovini D, Orefice S (1980) Prognosis of stage I melanoma of the skin. WHO collaborating centres for evaluation of methods of diagnosis and treatment of melanoma. Int J Cancer 26:733–739

    Google Scholar 

  6. Davis NC, McLeod GR, Beardmore GL, Little JH, Quinn RL, Holt J (1976) Primary cutaneous melanoma: a report from the Queensland melanoma project. CA 26:80

    Google Scholar 

  7. Day CL, Sober AJ, Fitzpatrick TB, Lew RA, Mihm MC (1980) Prognosis in malignant melanoma. Am Acad Dermatol 3:525–526

    Google Scholar 

  8. Day CL, Mihm MC, Sober AJ, Haris MN, Kopf AW, Fitzpatrick TB, Lew RA, Harrist TJ, Golomb FM, Postel A, Hennessey P, Gumport SL, Rahe JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Rigel D, Friedman RJ, Mintzis MM (1982) Prognostic factors for melanoma patients with lesions 0.76–1.69 mm in thickness. Ann Surg 195:30–34

    Google Scholar 

  9. Eldh J, Boeryd N, Peterson L-E (1978) Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg 12:243–255

    Google Scholar 

  10. Esch EP van der, Heite HJ, Kuehnl-Petzoldt Ch (1974) A model of punchcard-coded description of histological structures in the primary cutaneous melanoma. EVD Med Biol 5:43–49

    Google Scholar 

  11. Esch EP van der, Cascinelli N, Preda F, Morabito A, Bufalino R (1981) Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer 48:1668–1673

    Google Scholar 

  12. Grond K (1979) Zur Prognose des Melanomalignoms. Z Hautkr 54:559–570

    Google Scholar 

  13. Heite HJ (1975) On the usual “mortality curve” in the case of the malignant melanoma. — Interpretation and consequences. Arch Dermatol Res 252:81–82

    Google Scholar 

  14. Heite HJ (1981) Ergebnisse der Arbeitsgemeinschaft Malignes elanom der Deutschen Forschungsgemeinschaft. Hautarzt [Suppl V] 32:11–19

    Google Scholar 

  15. Huvos AG, Shab JP, Mike V (1974) Prognostic factors in cutaneous malignant melanoma. A comparative study of longterm and short-term survivors. Hum Pathol 5:347–357

    Google Scholar 

  16. Kapelanski DP, Block GE, Kaufman M (1979) Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy. Ann Surg 189:225–235

    Google Scholar 

  17. Kuehnl-Petzoldt Ch, Wiebelt H, Berger H (1983) Malignes Melanom: Prognostische Beurteilung durch Korrelationskoeffizienten. Hautarzt 34:398–402

    Google Scholar 

  18. Kuehnl-Petzoldt Ch, Wiebelt H, Berger H, Wagner G (1983) A proposal for staging malignant melanoma. Arch Dermatol Res 275:255–256

    Google Scholar 

  19. Kuehnl-Petzoldt Ch, Wiebelt H, Berger H (1983) Prognostic groups of patients with stage I melanoma. Arch Dermatol 119: 816–819

    Google Scholar 

  20. Kuehnl-Petzoldt Ch, Wiebelt H, Berger H (1984) In what sense are break-points prognostic in malignant melanoma. Am J Dermatopathol (in press)

  21. Magnus K (1977) Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis. Cancer 40:389–397

    Google Scholar 

  22. Magnus K (1981) Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site. Cancer 48:2329–2335

    Google Scholar 

  23. McGovern VJ, Shaw HM, Milton GW, Farago GA (1979) Prognostic significance of the histological features of malignant melanoma. Histopathology 3:385–393

    Google Scholar 

  24. Pathak DR, Samet JM, Howard CA, Key CR (1982) Malignant melanoma of the skin in New Mexico 1969–1977. Cancer 7:1440–1446

    Google Scholar 

  25. Pondes S, Hunter JAA, White H, McIntyre MA, Prescott RJ (1981) Cutaneous malignant melanoma in South-east Scotland. Quarterly J Med, New Series L, 50:103–121

    Google Scholar 

  26. Rampen F (1980) Malignant melanoma: sex differences in survival after evidence of distant metastasis. Br J Cancer 42:52–57

    Google Scholar 

  27. Roberts G, Martyn, Dobson AJ, McCarthy WH (1981) Tumor thickness and histological type in malignant melanoma in New South Wales, Australia, 1970–76. Pathology 13:763–770

    Google Scholar 

  28. Schmoeckel Ch, Braun-Falco O (1978) Prognostic index in malignant melanoma. Arch Dermatol 114:871–873

    Google Scholar 

  29. Schmoeckel Ch, Bockelbrink A, Bockelbrink H, Koutsis J, Braun-Falco O (1983) Low and high risk malignant melanoma I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer Clin Oncol 19:227–235

    Google Scholar 

  30. Schmoeckel Ch, Bockelbrink A, Bockelbrink H, Kistler H, Braun-Falco O (1983) Low and high risk malignant melanoma. III. Prognostic significance of the resection margin. Eur J Cancer Clin Oncol 19:245–249

    Google Scholar 

  31. Shaw HM, McGovern VJ, Milton GW, Fargo GA, McCarthy WH (1981) Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 45:1604–1608

    Google Scholar 

  32. Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH (1981) Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer 46:2731–2735

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Neuropathologie, Pathologisches Institut der Universität, Albertstr. 19, D-7800, Freiburg i. Br.

    C. Kuehnl-Petzoldt

  2. Universitäts-Hautklinik, D-7800, Freiburg i. Br., Federal Republic of Germany

    H. Keil & E. Schoepf

Authors
  1. C. Kuehnl-Petzoldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Keil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Schoepf
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuehnl-Petzoldt, C., Keil, H. & Schoepf, E. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (≤1.5 mm) melanoma. Arch Dermatol Res 276, 151–155 (1984). https://doi.org/10.1007/BF00414011

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00414011

Key words

Search

Navigation